secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001193125-26-059349
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm shareholders approve increase in authorized shares to 111M at special meeting
--------------------------------------------------------------------------------

- Authorized common stock raised from 53,333,333 to 106,000,000; total capital shares from 58,333,333 to 111,000,000.
- Vote: 9,436,123 for, 3,213,329 against, 25,465 abstain; adjournment proposal also approved but not needed.
- Certificate of amendment filed with Delaware Secretary of State on February 18, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/0001193125-26-059349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312526059349/kpti-20260218.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-059349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer